DexCom Inc. closed 34.58% short of its 52-week high of $132.26, which the company reached on May 17th.

Dexcom Inc. defeated investor allegations the glucose monitor maker overhyped its growth potential before a nearly 41% stock drop, a federal judge ruled.

Shares of DexCom Inc. DXCM shed 1.11% to $84.11 Tuesday, on what proved to be an all-around mixed trading session for the ...

The medical instruments industry is currently undergoing a transformative phase, thanks to the rapid adoption of generative ...

After this recent quarterly performance and the resultant increase in stock price, an important question arises: is DXCM ...

Dexcom (Nadsaq:DXCM) shares rose after hours today on first-quarter results that came in mixed compared to the consensus ...

DexCom (DXCM) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the ...

DexCom, Inc. (NASDAQ: DXCM) has once again demonstrated its formidable position in the continuous glucose monitoring (CGM) ...

DexCom (DXCM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). Five Health and Fitness stocks to buy now are ...

So even in these challenging times, it's a good idea to look for stocks worth investing in for the next decade and beyond.

The Oura Ring 4 is rapidly becoming the center piece of your efforts to lead a healthier life, and the introduction of two ...